Diabetes Complications Flashcards

1
Q

Long term complications of diabetes

A

-microvascular disease
-macrovascular disease
-periodontal diseases
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Microvascular disease

A

-diabetic kidney disease nephropathy
-ocular complications
-neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Macrovascular disease

A

-cardiovascular disease
-stroke
-peripheral vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diabetic kidney disease (neuropathy)

A

-proteinuria
-low GFR
-inc BP
-20-40% of pt w DM
-major cause of death in type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

kidney disease monitoring

A

-screen for microalbuminuria
-optimize glucose control
-optimize blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

microalbuminuria screening

A

-annual test to detect early kidney damage
-test all T2DM pt and pt w T1DM for over 5 years
-UACR and eGFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

goal UACR

A

<30mg/g
-urinary-albumin-to-creatinine ration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

if UACR > 300mg/g or eGFR < 60mL/min/1.73m

A

-monitor twice a year
-ACEI or ARB tx (not for pregnant pts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Optimizing glucose control in T2DM + kidney disease

A
  1. SGLT2I w evidence of low CKD progression is eGFR > 20mL and UACR > 200mg/g or if UACR is normal (jardiance)
  2. GLP-1 w CVD benefit if SGLT2 not tolerated/contraindicated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Optimizing BP control in diabetes w kidney disease

A

-goal: < 130/80
-dont discontinue ACEI or ARB for small increases in SCr (<30%)
-consider SGLT2, GLP-1, or nonsteroidal mc receptor antagonist
-goal is 30% reduction if UACR > 300 mg/g
-limit protein intake to 0.8mg/kg/day for non-dialysis pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ocular Complications (microvasc)

A

-blurred vision, cataracts, glaucoma
-retinopathy (most common)
-appears 15-20 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Retinopathy

A

-most common cause of blindness
-pregnancy can make it worse
-appears in 15-20 years
-get eye exams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Retinopathy tx

A

-optimize glycemic control, BP, and lipid management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Retinopathy screening

A

-T1DM within 5 years of diagnosis
-T2DM at diagnosis
-exam every 1-2 years
-annually if retinopathy present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neuropathy

A

-peripheral
-gastrointestinal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

peripheral neuropathy tx

A

-annual monofilament test
-pregabalin, duloxetine, gabapentin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Gastrointestinal neuropathies

A

-gastroparesis
-diarrhea/constipation
-fecal incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

other microvascular complications

A

-urinary retention
-postural hypotension (drop BP when moving)
-erectile dysfunction

tx: optimize blood sugar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Macrovascular complications

A

-Artherosclerotic CVD
-heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Atherosclerotic CVD

A

-coronary heeart disease
-cerebrovasc disease
-peipheral arterial disease
-leading cause of death in type 2 pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Heart failure

A

-major cause of death
-hospitilizations are twice as high in DM pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ASCVD or HF tx

A

-optimize tx of DM
-SGLT2
-GLP-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

CVD monitoring

A

-assess risk factors annually
-obesity, HTN, HLD, smoking, CKD
-metabolic syndrome: obesity, htn, hld

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ADA BP goal (same as ACC)

A

< 130/80 for T2 or T1
-110-135/85 for DM + pregnancy

-<140 SBP ok for elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
HTN tx in T2DM
1. ACEIs or ARBs -slow progression of proteinuria -DO NOT USE BOTH in one pt -use at max tolerated dose 2. HCTZ, chlorthalidone, amlodipine, MRAs next
26
ACEI and ARB combo
-dont combo -hyperkalemia, syncope, renal dysfunction
27
When to use statin for primary CV prevention
-low risk pt none to moderate statin dose -over 40 w more than one risk factor = high intensity statin
28
LDL target in primary prevention
-dec by more than 50% -goal: < 70
29
statin use for 2' prevention
-high intensity + LSM -ezetimibe or PCSK9 if LDL still high
30
LDL target in 2' prevention
-LDL < 55
31
intolerant to statin therapy in 2' prevention:
-PCSK9 inhibitor therapy w mAb tx -bempedoic acid therapy -PCSK9 therapy w inslisinan siRNA
32
more generally, recommendation for DM pt 40-75
-primary prevention: moderate to high intensity statin -secondary prevention: high intensity statin and goal LDL < 70 (?) (ACC guidelines prob not updated)
33
High intensity statin recs
-atorvastatin 40-80 mg/day -Rosuvastatin 20-40 mg/day
34
Moderate intensity statin recs
-atorvastatin 10-20 -rosuvastatin 5-10 -simvastatin 20-40 -pravastatin 40-80 -lovastatin 40 -fluvastatin 80 -pitavastatin 1-4
35
rx for statin intolerance
-bempedoic acid
36
statin dosing tips
-muscle pain -start at low dose and titrate up
37
Stroke tx
-keep BP under control -smoking cessation
38
Peripheral vascular disease
-amputations -leg pain, cold feet, absent pulses
39
peripheral vascular disease tx
-correct risk factors -exercise -surgery
40
Periodontal disease
-sugar damage to teeth
41
Use of antiplatelet agents (2' prevention)
-aspirin 75-162mg/day in DM + ASCVD -clopidogrel 75 if allergy -sometimes combine aspirin and P2Y12 inhibitor (bleeding risk)
42
aspirin + rivaroxaban therapy
-for pt w stable coronary or peripheral artery disease and low bleeding risk -prevent limb and CV events
43
Consider aspirin for primary prevention if
-over 50 w risk factor that are not at increased risk of bleeding -d/c over 70 -dont use if low CVD risk not worth it
44
DM monitoring parameters
-signs and sx -blood glucose tests -glycosylated hemoglobin
45
Blood glucose tests
-fasting target 80-130 mg/dL**** -after meal: <180 or <140 -bedtime glucose 90-150mg/dL
46
Self-monitoring blood glucose (SMBG)
-intensive insulin regimens -basal insulin +/- non-insulin meds -non-insulin regimens
47
Intensive insulin regimens (self monitoring)
-prior to meals and bedtime -prior to snacks or activity -suspicion of hypoglycemia and after tx
48
basal insulin +/- noninsulin regimen self-monitoring
-once daily while fasting
49
non-insulin regimen self-monitoring
as needed
50
Continuous Glucose Monitoring (CGM)
-decrease hypoglycemia and improve A1c readings
51
CGM goals
-generally 70-80 -idk man
52
Glycosylated hemoglobin (A1c)
-normal 4-6% -DM might be 10-15% -target less than 7%!! -target 6% in pregnancy -reflects average blood glucose over the past 8-12 weeks
53
benefits of A1c reduction DCCT type 1
-60% reduction in retinopathy, nephropathy, neuropathy -42% reduction in CVD -57% reduction in MI, stroke, CVD death -A1c 9 to 7 -type 1
54
benefits of A1c lowering type 2 (UKPDS)
-25% reduction in microvasc complications -16% reduction in fatal or nonfatal MI and sudden death -every 1% drop = 18% reduction in CVD risk
55
ACCORD trial
-ended study early
56
VADT trial
-
57
bottom line of a1c trials
-more aggressive therapy for newly diagnosed, no severe hypoglycemia, no CVD -caution for severe hypoglycemia, CVD, advanced disease
58
A1c to eAG ratio
-1% A1c = 28.7 inc in blood glucose
59
Advantages of A1c monitoring
-can measure w/o fasting -levels not subject to acute changes in insulin dosing, exercise, diet
60
Disadvantages of A1c monitoring
-does NOT replace SMBG or CGM -its an average of all numbers -conditions that affect RBC turnover will impact results
61
when to check A1c
-twice a year if meeting goals -4 times if not
62
PPG contribution to A1c
-when A1c is high, fasting BG is contributing most -closer to 7%: target postprandial BG
63
Monitoring parameters
-urine tests -BUN/SCr -fasting lipid profile -BP -electrolytes
64
Urine tests
-urine glucose -urine ketones (esp type 1) -microalbuminuria